Vladimir Lazar

12.2k total citations
133 papers, 7.4k citations indexed

About

Vladimir Lazar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Vladimir Lazar has authored 133 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 54 papers in Cancer Research and 43 papers in Oncology. Recurrent topics in Vladimir Lazar's work include Cancer Genomics and Diagnostics (35 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer-related Molecular Pathways (10 papers). Vladimir Lazar is often cited by papers focused on Cancer Genomics and Diagnostics (35 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer-related Molecular Pathways (10 papers). Vladimir Lazar collaborates with scholars based in France, United States and Belgium. Vladimir Lazar's co-authors include Philippe Dessen, Razelle Kurzrock, Maria Schwaederlé, Richard L. Schilsky, John Mendelsohn, J. Jack Lee, Ludovic Lacroix, Guido Kroemer, Alexander M.M. Eggermont and Jean-Michel Bidart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Vladimir Lazar

130 papers receiving 7.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vladimir Lazar France	46	4.1k	2.1k	2.1k	974	954	133	7.4k
Giuseppe Viglietto Italy	48	5.4k 1.3×	2.3k 1.1×	1.6k 0.7×	687 0.7×	803 0.8×	150	8.2k
Carl Morrison United States	45	4.2k 1.0×	2.3k 1.1×	2.4k 1.1×	747 0.8×	1.3k 1.4×	185	8.1k
Amit Maity United States	45	3.4k 0.8×	2.7k 1.3×	1.9k 0.9×	1.0k 1.0×	1.2k 1.3×	153	7.2k
Mark A. Watson United States	48	3.4k 0.8×	1.9k 0.9×	1.7k 0.8×	457 0.5×	1.4k 1.5×	129	7.2k
Antonio Di Cristofano United States	37	6.7k 1.7×	2.1k 1.0×	1.5k 0.7×	1.2k 1.2×	1.0k 1.1×	75	9.1k
Paul N. Span Netherlands	57	5.1k 1.3×	2.5k 1.2×	3.1k 1.5×	785 0.8×	1.3k 1.4×	233	9.7k
Qianxing Mo United States	39	3.2k 0.8×	1.8k 0.8×	1.0k 0.5×	845 0.9×	933 1.0×	138	6.2k
David W. Dawson United States	42	3.9k 1.0×	2.3k 1.1×	1.5k 0.7×	774 0.8×	556 0.6×	106	7.2k
Jaime Rodriguez‐Canales United States	44	2.7k 0.7×	2.9k 1.3×	1.7k 0.8×	1.3k 1.3×	1.3k 1.3×	163	6.8k
Hui‐Kuan Lin United States	53	7.6k 1.9×	2.3k 1.1×	2.4k 1.2×	1.1k 1.1×	1.8k 1.9×	120	10.7k

Countries citing papers authored by Vladimir Lazar

Since Specialization

Citations

This map shows the geographic impact of Vladimir Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Lazar more than expected).

Fields of papers citing papers by Vladimir Lazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Lazar. The network helps show where Vladimir Lazar may publish in the future.

Co-authorship network of co-authors of Vladimir Lazar

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Lazar. A scholar is included among the top collaborators of Vladimir Lazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Lazar. Vladimir Lazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kundu, Kiran, Susmita Ghosh, Rhitajit Sarkar, et al.. (2019). Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA. Cancer Immunology Research. 7(7). 1120–1134. 29 indexed citations

Schwaederlé, Maria, Vladimir Lazar, Pierre Validire, et al.. (2015). VEGF-A Expression Correlates with TP53 Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy. Cancer Research. 75(7). 1187–1190. 96 indexed citations

Albigès, Laurence, Aïcha Goubar, Véronique Scott, et al.. (2014). Chk1 as a new therapeutic target in triple-negative breast cancer. The Breast. 23(3). 250–258. 46 indexed citations

Quidville, Virginie, Samar Alsafadi, Aïcha Goubar, et al.. (2013). Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy. Cancer Research. 73(7). 2247–2258. 75 indexed citations

Dutta, Bhaskar, Lajos Pusztai, Yuan Qi, et al.. (2012). A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. British Journal of Cancer. 106(6). 1107–1116. 37 indexed citations

Arnedos, Mónica, Véronique Scott, Bastien Job, et al.. (2012). Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancer. European Journal of Cancer. 48(15). 2293–2299. 18 indexed citations

Desterke, Christophe, Chrystèle Bilhou‐Nabera, Bernadette Guerton, et al.. (2011). FLT3-Mediated p38–MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis. Cancer Research. 71(8). 2901–2915. 35 indexed citations

Friboulet, Luc, Frédéric Commo, Ken A. Olaussen, et al.. (2011). Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC. Clinical Cancer Research. 17(17). 5562–5572. 54 indexed citations

Galluzzi, Lorenzo, Eugenia Morselli, Ilio Vitale, et al.. (2010). miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death. Cancer Research. 70(5). 1793–1803. 239 indexed citations

10.

Locatelli, Giuseppe, Roberta Bosotti, Marina Ciomei, et al.. (2010). Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study. Molecular Cancer Therapeutics. 9(5). 1265–1273. 11 indexed citations

11.

Broutin, Sophie, Corinne Dupuy, Bernard Caillou, et al.. (2009). Abstract# 1788: In vitro and in vivo activity of vandetanib in a human medullary thyroid carcinoma model bearing a RETC634W activating mutation. Cancer Research. 69. 1788–1788. 2 indexed citations

12.

André, Fabrice, Bastien Job, Philippe Dessen, et al.. (2009). Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array. Clinical Cancer Research. 15(2). 441–451. 248 indexed citations

13.

André, Fabrice, Stefan Michiels, Philippe Dessen, et al.. (2009). Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. The Lancet Oncology. 10(4). 381–390. 46 indexed citations

14.

Bénard, Jean, Gilda Raguénez, Audrey Kauffmann, et al.. (2008). MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S. Molecular Oncology. 2(3). 261–271. 50 indexed citations

15.

Kannengiesser, Caroline, Alan Spatz, Stefan Michiels, et al.. (2008). Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas. Molecular Oncology. 1(4). 425–430. 36 indexed citations

16.

Fabre, Stéphanie, Florent Carrette, Jing Chen, et al.. (2008). FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase. The Journal of Immunology. 181(5). 2980–2989. 148 indexed citations

17.

Rouge, Thibault De La Motte, Lorenzo Galluzzi, Ken A. Olaussen, et al.. (2007). A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib. Cancer Research. 67(13). 6253–6262. 109 indexed citations

18.

Lévy, Pascale, Hugues Ripoche, Ingrid Laurendeau, et al.. (2007). Microarray-Based Identification of Tenascin C and Tenascin XB , Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1. Clinical Cancer Research. 13(2). 398–407. 43 indexed citations

19.

Lazar, Vladimir, Pierre Validire, Sophie Richon, et al.. (2002). Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. British Journal of Cancer. 86(8). 1283–1289. 21 indexed citations

20.

Lazar, Vladimir, et al.. (1984). Levels of Plasma Testosterone in Ganders as Related to Egg Fertilization Rate. Acta Veterinaria Brno. 53(3-4). 151–158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact